Summary
This 8-K filing from CVS Health Corporation provides crucial updates regarding the anticipated closing of its acquisition of Aetna Inc. and key executive appointments. The company has made significant progress with state insurance department approvals, receiving clearance from 26 out of 28 states and is in the final stages for the remaining two. This has led to an updated expectation that the Aetna acquisition will close shortly after the Thanksgiving holiday. Additionally, in preparation for the acquisition's close, CVS Health announced changes in its finance leadership. Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer, and James D. Clark has been appointed Senior Vice President – Controller and Chief Accounting Officer. These appointments were anticipated and are effective immediately. The filing also confirms the departure of David M. Denton, the outgoing Executive Vice President and Chief Financial Officer, with his separation agreement terms remaining unchanged, except for his departure date which is now effective immediately. Investors should note that while the Aetna acquisition is nearing completion, forward-looking statements made in this report are subject to significant uncertainties and risks, as detailed in CVS Health's other SEC filings.
Key Highlights
- 1CVS Health expects the Aetna acquisition to close after the Thanksgiving holiday, with 26 out of 28 required state insurance department approvals secured.
- 2Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer, effective November 19, 2018.
- 3James D. Clark has been appointed Senior Vice President – Controller and Chief Accounting Officer, effective November 19, 2018.
- 4David M. Denton, the current CFO, will depart CVS Health effective November 19, 2018, under his previously announced separation terms.
- 5The company is in the final stages of obtaining approvals from the two remaining state insurance departments.
- 6This filing provides an update on the previously announced executive appointments and executive departure in anticipation of the Aetna acquisition closing.